Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sea cucumber peptide is a mixture of small-molecule peptides derived from the enzymatic hydrolysis of proteins found in the body wall or viscera of sea cucumbers. The main component is collagen-derived peptides, with molecular weights typically less than 600 Da. Sea cucumber peptide exhibits a range of biological activities including antioxidant, anti-inflammatory, immunomodulatory, and potential neuroprotective effects. Studies have shown that it can modulate gut microbiota composition and inhibit M1 macrophage polarization via FPR2-mediated pathways in animal models of ulcerative colitis[2][4]. It also demonstrates strong free radical scavenging activity in vitro and may improve memory impairment[4][5]. Sea cucumber peptide is primarily developed as a dietary supplement or functional food ingredient for health maintenance rather than as a pharmaceutical drug[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sea cucumber peptide.